Showing 8431-8440 of 18147 results for "".
- Older Adults with Diabetes Experienced Functional Decline During the COVID-19 Pandemichttps://reachmd.com/news/older-adults-with-diabetes-experienced-functional-decline-during-the-covid-19-pandemic/2462764/Toronto, ON —Researchers found that approximately 1 in 5 older Canadian adults with diabetes and no pre-pandemic functional limitations developed functional limitations for the first time during the COVID-19 pandemic. Functional limitations refe
- Autonomous Artificial Intelligence Increases Screening and Follow-Up for Diabetic Retinopathy in Youth: The ACCESS Randomized Control Trialhttps://reachmd.com/news/autonomous-artificial-intelligence-increases-screening-and-follow-up-for-diabetic-retinopathy-in-youth-the-access-randomized-control-trial/2462372/Trial designACCESS is a hypothesis-driven, pre-registered, prospective parallel, RCT with a 1:1 allocation ratio that was conducted at the Johns Hopkins Pediatric Diabetes Center at two sites (Johns Hopkins Hospital and Mount Washington Pediatric Hospital) in Baltimore, Marylan
- Study Shows liraglutide Results in Increased Insulin Sensitivity Independent of Weight Losshttps://reachmd.com/news/study-shows-liraglutide-results-in-increased-insulin-sensitivity-independent-of-weight-loss/2456767/by Jill Clendening A new study published in the journal Diabetes demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat Type
- AI-Powered Retinal Imaging Enhances Early Detection of Diabetic Retinopathyhttps://reachmd.com/news/ai-powered-retinal-imaging-enhances-early-detection-of-diabetic-retinopathy/2471754/A Breakthrough in Automated Eye Disease Diagnosis A research team from Skoltech, the University of Sharjah, and the AIRI Institute has developed an AI-powered system to analyze retinal images, potentially transforming how dia
- Balancing Benefits and Risks: Ozempic's Impact on Health Beyond Diabeteshttps://reachmd.com/news/balancing-benefits-and-risks-ozempics-impact-on-health-beyond-diabetes/2471012/What's New New findings highlight Ozempic's dual role in enhancing cardiovascular health while posing gastrointestinal challenges. Significance Understanding both the benefits and risks is essential for clinicians in making informed treatment decisio
- Heart Organoids Simulate Pregestational Diabetes-Induced Congenital Heart Diseasehttps://reachmd.com/news/heart-organoids-simulate-pregestational-diabetes-induced-congenital-heart-disease/2457114/High magnification confocal image of cardiomyocytes in the myocardial tissue of an organoid. Notice the banded structure of sarcomeres (the contracting units of the heart). Red: cardiomyo
- Therapeutic Plasma Exchange in HELLP Syndrome: Emerging Insights and Clinical Applicationshttps://reachmd.com/news/therapeutic-plasma-exchange-in-hellp-syndrome-emerging-insights-and-clinical-applications/2485007/Therapeutic plasma exchange produced rapid clinical reversal in a critically ill postpartum patient with refractory thrombotic microangiopathy/HELLP,
- Evaluating the Impact of Added Sugars in US Infant Formula on Baby Healthhttps://reachmd.com/news/evaluating-the-impact-of-added-sugars-in-us-infant-formula-on-baby-health/2471316/Assessing How Early Sugar Exposure Shapes Long-Term Health Outcomes This article explores concerns over high levels of added sugar in US infant formula, examining evidence that links early exposure to added sugars with an increased risk of obesity, type 2 diabetes,
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://reachmd.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2474319/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick sk
- Streamlining Healthcare Technology and Patient Adherence: Addressing 504 Errors and Diabetic Retinopathy Screeninghttps://reachmd.com/news/streamlining-healthcare-technology-and-patient-adherence-addressing-504-errors-and-diabetic-retinopathy-screening/2471244/In the intersection of healthcare technology and patient care, understanding technical hurdles like 504 Gateway Time-out errors and improving patient adherence to screenings for conditions such as diabetic retinopathy can significantly influence outcomes.